2nd Quarter - Report

HEALTH AND MEDICINE COUNSEL for DIGESTIVE DISEASE NATIONAL COALITION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$10,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 2, 2024 $10,000 Replaced
2nd Quarter - Amendment Sep 18, 2025 $10,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

-Broad NIH Funding and specifically NIDDK Funding -Cancer Moonshot Funding -ARPA-H Funding -Defense PRMRP and PRCRP Funding -VA Medical and Prosthetics Research Program Funding -CDC Colorectal Cancer Prevention Program Funding -CDC Division of Viral Hepatitis Funding -CDC Inflammatory Bowel Disease Funding -CDC Chronic Disease Education and Awareness Program Funding

LobbyistCovered position, as disclosed
DANE CHRISTIANSEN Legislative Consultant
PHILIP GOGLAS Legislative Consultant
DYLAN REID MOSKOWITZ Legislative Consultant /Washington Representative

Contacted: Natl Institutes of Health (NIH); SENATE; Centers For Disease Control & Prevention (CDC); Defense, Dept of (DOD); Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES

Health Issues HCR

-Safe Step Act -HELP Copays Act

LobbyistCovered position, as disclosed
DANE CHRISTIANSEN Legislative Consultant
PHILIP GOGLAS Legislative Consultant
DYLAN REID MOSKOWITZ New Legislative Consultant

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Centers For Disease Control & Prevention (CDC); SENATE; Natl Institutes of Health (NIH); Veterans Affairs, Dept of (VA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.